BioSpace News Archive

Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that the Company plans to release its first quarter fiscal year 2021 financial results on Tuesday, September 8, 2020, after the close of trading.

Myomo, Inc. today announced that it will be presenting at the LD 500 investor conference on Wednesday, September 2, 2020 at 11:00 a.m. EDT.

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the 2020 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 10, 2020. About Electromed, In

Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ), announces that the Company will be relying on the temporary 45 day extension to the filing deadline of its interim financial statements and management’s discussion and analysis (“MD&A”) for the quarter ended June 30, 2020 granted by the Alberta Securities Commission (“ASC”) in response to unprecedented challenges resulting from COVID-19. The noti

- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced its management team will present at two upcoming investor conferences: The Baird 2020 Global Healthcare Conference, on Wednesday, September 9, 2020 at 12:50pm ET The 2020 Cantor Global Virtual Healthcare Conference, on Thursday, September 17, 2020 at 12:40pm ET A live audio webcast and replay of the

The importance of gut microbiota in reducing the burden of alcohol-related liver disease and liver cancer has been demonstrated in a novel pilot study presented at The Digital International Liver Congress™ 2020.

Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, will delay the release of its financial results for the second quarter ended June 30, 2020 and subsequent earnings conference call, previously scheduled for Friday, August 28th to Monday, August 31, 2020 at 5:30 p.m. ET. The Company will file its financial statements and report its financial results via press release af

FDA Approves FoundationOne ® Liquid CDx to Serve as Rubraca ® (rucaparib) Companion Diagnostic to Identify Eligible Patients with BRCA1/2 -Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC) FDA-approved plasma-based companion diagnostic provides advantages for patients and practices BOULDER, Colo.--( BUSINESS WIRE )-- Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the U.S. Food and Drug Administration (FDA) approved the F

Fortress Biotech, Inc., an innovative biopharmaceutical company, announced that it has priced an underwritten public offering of 666,666 shares of its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock at a price of $18.00 per share, with expected gross proceeds to Fortress of approximately $12 million.

Fionet is a first-of-its-kind mobile testing platform for organizations to manage and track on-site COVID-19 testing